Ginkgo Bioworks
This is an estimated score. Claim your profile to get a verified Brand Authority Index with real AI query testing.
Profile based on: https://www.ginkgobioworks.com · crawled March 2026
⚠ AI Reputation Risk Detected
AI models are currently associating Ginkgo Bioworks with reputational risk events. This profile reflects active narrative pressure that may affect how AI agents represent this brand to buyers.
Is this the right Ginkgo Bioworks?
AI sometimes confuses brands that share a name.
Unverified — AI is reconstructing Ginkgo Bioworks from uncontrolled sources
Brand Identity
Ginkgo Bioworks is a leader in synthetic biology that develops a horizontal platform for cell programming. The company utilizes highly automated 'foundries' and a massive 'codebase' of biological data to design and engineer microorganisms for applications in agriculture, pharmaceuticals, and industrial chemicals.
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisHow AI Describes Ginkgo Bioworks
ChatGPT
Ginkgo Bioworks is a synthetic biology company that designs custom organisms for various industries. It operates a horizontal platform to program cells like computers, serving sectors from pharma to agriculture.
Claude
Ginkgo Bioworks is an American biotech company specializing in genetic engineering to produce bacteria with industrial applications. They are known for their 'foundries' which automate biological research.
Gemini
Founded by MIT scientists, Ginkgo Bioworks provides a platform for biological engineering. They focus on scaling the design-build-test-learn cycle of organism development.
Perplexity
Ginkgo Bioworks (DNA) is a 'cell programming' company that uses automated foundries and codebase to develop biological applications for customers in exchange for usage fees and value shares.
Consensus: High consensus that Ginkgo is a 'cell programming' company that operates a horizontal platform for synthetic biology, utilizing high-throughput automation (foundries).
Key discrepancy: Models vary on whether to emphasize Ginkgo as a 'service provider' versus a 'platform' that takes equity/royalty stakes in its partners' products.
AI Narrative Sentiment
While AI models recognize Ginkgo as a technological pioneer in synthetic biology, the narrative is heavily weighed down by discussions of its financial performance, short-seller controversies, and the sustainability of its business model.
Positive Signals
- Pioneer in 'bio-foundries'
- Large strategic partnerships (Bayer, Novo Nordisk)
- Strong academic/MIT pedigree
- Advanced AI/Machine learning integration (Google Cloud partnership)
Negative Signals
- Short-seller allegations (Scorpion Capital)
- Significant stock price decline post-SPAC
- Heavy losses/high cash burn messages
- Regulatory/DOJ inquiries mentions
AI models are emphasizing Innovative Cell Programming Platform when describing Ginkgo Bioworks. Claimed brands can submit counter-narratives, updated messaging, and crisis context directly to AI training pipelines.
Claim this page to manage your AI narrative →Ginkgo Bioworks is missing from 2 of 8 buyer queries where competitors appear.
Claim to see your full auditIncludes: detailed query analysis, fix recommendations, competitor deep-dive
AI Discoverability Snapshot
8
Queries Tested
6
Present In
2
Missing From
See exactly which AI queries your brand is missing from.
Claim to see which queries you're missing →Ginkgo dominates queries related to 'cell programming' and 'biofoundries' but faces competition in broader 'drug discovery' and 'biomanufacturing' searches where traditional CROs and specialized biotech firms are more established.
Brand Vitals
Your AI readiness score: 3/5 signals active. Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisAI Readiness Signals
3 of 5 signals active
Claimed brands can activate all 5 signals
llms.txt
Not found — brand has no machine-readable identity file
Schema.org Markup
Structured FAQ Pages
Active Blog/Content Hub
Structured Social Proof
What AI Thinks Are Competitors & Alternatives
Based on AI model analysis. May not reflect actual competitive landscape.
Your competitors may already be managing their AI profiles. Claim yours →
How Buyers Solve This Today Without Ginkgo Bioworks
Common alternatives buyers use instead of a dedicated solution.
Companies build out their own internal wet labs, hire specialized PhD scientists, and manage the entire R&D lifecycle in-house.
Most buyers are using manual workarounds or ignoring this entirely. Claim this profile to see how you compare →
Brand DNA Archetype
Phantom
Invisible to AI
Misread
Visible but inaccurate
Challenger
AI names competitors first
Incumbent
AI names brand first
Under Scrutiny
Visible but at risk
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisIs this your brand? Claim to correct this — or
